Best Practice & Research Clinical Rheumatology
Volume 21, Issue 3 , Pages 481-497 , June 2007

Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain

  • Muhammad B. Yunus, MD, FACP, FACR, FRCPE (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 309 671 8430; Fax: +1 309 671 8513.

References 

  1. Yunus MB. The concept of central sensitivity syndromes. In:  Wallace DJ,  Clauw DJ editor. Fibromyalgia and Other Central Syndromes. 1st ed.. Philadepphia: Lippincott Williams & Wilkins; 2005;p. 29–44
  2. Yunus MB. Fibromyalgia and overlapping disorders: a unifying concept of central sensitivity syndromes. Seminars in Arthritis and Rheumatism (in press).
  3. Yunus MB. Symptoms and signs of fibromyalgia syndrome: an overview. In:  Wallace DJ,  Clauw DJ editor. Fibromyalgia and Other Central Syndromes. 1st ed.. Philadepphia: Lippincott Williams & Wilkins; 2005;p. 125–132
  4. Nicassio PM, Moxham EG, Schuman CE, Gevirtz RN. The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain. 2002;100:271–279
  5. Kent-Braun JA, Sharma KR, Weiner MW, et al. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology. 1993;43:125–131
  6. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Annals of the Rheumatic Diseases. 1997;56:268–271
  7. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. British Medical Journal. 1994;309:696–699
  8. McBeth J, Macfarlane J, Benjamin S, et al. The association between tender points, psychological distress and adverse childhood experiences. Arthritis and Rheumatism. 1999;42:1397–1404
  9. Vecchiet L, Montanari G, Pizzigallo E, et al. Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome. Pain. 1996;208:117–120
  10. Whiteside A, Hansen S, Chaudhuri A. Exercise lowers pain threshold in chronic fatigue syndrome. Pain. 2004;109:497–499
  11. Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis and Rheumatism. 2001;44:222–230
  12. Agargun MY, Takeoglu I, Gunes A, et al. Sleep quality and pain threshold in patients with fibromyalgia. Comprehensive Psychiatry. 1999;40:226–228
  13. Martinez- Lavin M, Hermosillo AG. Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Seminars in Arthritis and Rheumatism. 2000;29:197–199
  14. Sieweke N, Birklein F, Riedl B, et al. Patterns of hyperalgesia in complex regional pain. Pain. 1999;80:171–177
  15. Yunus MB, Masi AT, Calabro JJ, et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Seminars in Arthritis and Rheumatism. 1981;11:151–171
  16. Deodhar AA, Fisher RA, Blacker CVR, Woolf AD. Fluid retention syndrome and fibromyalgia. British Journal of Rheumatology. 1994;33:576–582
  17. Yunus MB, Ahles TA, Aldag JC, Masi AT. Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis and Rheumatism. 1991;34:15–21
  18. Yunus MB. Central sensitivity syndromes: a unified concept for fibromyalgia and other similar maladies. Journal of Indian Rheumatism Association. 2000;8:27–33
  19. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Annals of Internal Medicine. 2001;134:868–881
  20. Bennett RM. Emerging concepts in the neurobiology of chrome pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clinic Proceedings. 1999;74:385–398
  21. Trimble KC, Farouk R, Pryde A, et al. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Digestive Diseases and Sciences. 1995;40:1607–1613
  22. Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 1997;41:505–512
  23. Mertz H, Naliboff B, Munakata J, Niazi N. Altered rectal perception is a biologic marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109:40–52
  24. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain. 2001;93:7–14
  25. Costantini M, Sturniolo GC, Zaninotto G, et al. Altered esophageal pain threshold in irritable bowel syndrome. Digestive Diseases and Sciences. 1993;38:206–212
  26. Coffin B, Bouhassira D, Sabate J-M, et al. Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome. Gut. 2004;53:1465–1470
  27. Dickhaus B, Mayer EA, Firooz N, et al. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. The American Journal of Gastroenterology. 2003;98:135–143
  28. Lembo T, Naliboff BD, Matin K, et al. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids. Pain. 2000;87:137–147
  29. Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headaches. Archives of Neurology. 1996;53:373–376
  30. Langemark M, Jensen K, Jensen TS, Olesen J. Pressure pain thresholds and thermal nociceptive thresholds in chronic tension-type headache. Pain. 1989;38:203–210
  31. Langemark M, Bach FW, Jensen TS, Olesen J. Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Archives of Neurology. 1993;50:1061–1064
  32. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Annals of Neurology. 2000;47:614–624
  33. Weissman-Fogel I, Sprecher E, Granovsky Y, Yarnitsky D. Repeated noxious stimulation of the skin enhances cutaneous perception of migraine patients in-between attacks: clinical evidence for cutaneous sub-threshold increase in membrane excitability of central trigeminovascular neurons. Pain. 2003;104:693–700
  34. Vingen JV, Pareja JA, Storen O, et al. Phonophobia in migraine. Cephalgia. 1998;18:243–249
  35. Drummond PD. Photophobia and autonomic response to facial pain in migraine. Brain. 1997;120:1857–1864
  36. de Tammaso M, Guido M, Giuseppe L, et al. Abnormal brain processing of cutaneous pain in migraine patients during the attack. Neuroscience Letters. 2002;333:29–32
  37. Nicolodi M, Sicuteri R, Coppola G, et al. Visceral pain threshold is deeply lowered far from the head in migraine. Headache. 1994;34:12–19
  38. Malow RM, Grimm L, Olson RE. Difference in pain perception between myofascial pain dysfunction patients and normal subjects: a signal detection analysis. Journal of Psychosomatic Research. 1980;24:303–309
  39. Svensson P, List T, Hector G. Analysis of stimulus-evoked pain in patients with myofascial temporomandibular pain disorders. Pain. 2001;92:399–409
  40. Maixner W, Fillingin R, Sigurdsson A, et al. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain. 1998;71–81
  41. Fillingim RB, Fillingim LA, Hollins M, et al. Generalized vibrotactile allodynia in a patient with temporomandibular disorder. Pain. 1998;75–78
  42. Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain. 1995;63:341–351
  43. Bajaj P, Bajaj P, Madsen H, Arendt-Nielsen L. A comparison of modality-specific somatosensory changes during menstruation in dysmenorrheic and nondysmenorrheic women. The Clinical Journal of Pain. 2002;18:180–190
  44. Giamberardino MA, Berkley KJ, Iezzi S, et al. Pain threshold variations in somatic wall tissues as a function of menstrual cycle, segmental site and tissue depth in non-dysmenorrheic women, dysmenorrheic women and men. Pain. 1997;71:187–197
  45. Hapidou EG, De Catanzaro D. Sensitivity to cold pressor pain in dysmenorrheic and non-dysmenorrheic women as a function of menstrual cycle phase. Pain. 1988;34:277–283
  46. Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. British Medical Journal. 1996;312:1339
  47. Stiasny-Kolster K, Magerl W, Oertel WH, et al. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain. 2004;127:773–782
  48. Bara-Jimenez W, Aksu M, Graham B, et al. Periodic limb movements in sleep: state-dependent excitability of the spinal cord reflex. Neurology. 2000;54:1609–1616
  49. Ness TJ, Powell-Boone T, Cannon R, et al. Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis. Journal of Urology. 2005;173:1983–1987
  50. Yunus MB. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres Clinical Rheumatology. 1994;8:811–837
  51. Bradley LA. Psychiatric co-morbidity in fibromyalgia. Current Pain and Headache Reports. 2005;9:79–86
  52. McBeth J, Silman AJ, Gupta A, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of widespread musculoskeletal pain: findings of a population based prospective cohort study. Arthritis and Rheumatism. 2007;56:360–371
  53. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of for a chronic pain condition. Human Molecular Genetics. 2005;14:135–143
  54. Glass JM. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions. Current Rheumtology Reports. 2006;8:425–429
  55. Park DC, Glass JM, Minear M, Crofford LJ. Cognitive function in fibromyalgia patients. Arthritis and Rheumatism. 2001;44:2125–2133
  56. Carli G, Suman AL, Biasi G, Marcolongo R. Reactivity to superficial and deep stimuli in patents with chronic musculoskeletal pain. Pain. 2002;100:259–269
  57. Lautenbacher S, Rollman GB, McCain GA. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain. 1994;59:45–53
  58. Granges G, Littlejohn G. Pressure pain threshold in pain- free subjects in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis and Rheumatism. 1993;36:642–646
  59. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with ‘fibrositis syndrome’ and healthy subjects. Psychosomatic Medicine. 1975;37:341–351
  60. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis and Rheumatism. 2003;48:1420–1429
  61. Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. Journal of Rheumatology. 2004;31:695–700
  62. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis and Rheumatism. 1994;37:1181–1188
  63. Morand EF, Miller MH, Whittingham S, Littlejohn GO. Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus. 1994;3:187–191
  64. Yunus MB. A comprehensive medical evaluation of patients with fibromyalgia syndrome. Rheumatic Diseases Clinics of North America. 2002;28:201–217
  65. Wolfe F, Smythe HA, Yunus MB, et al. The 1990 criteria for classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis and Rheumatism. 1990;33:160–172
  66. Yunus MB, Inanici F, Aldag JC. Incomplete fibromyalgia: comparison with fibromyalgia syndrome. Arthritis and Rheumatism. 1998;41(suppl 9):S258
  67. Vargas A, Vargas A, Hernandez-Paz R, et al. Spygmomenometry-evoked allodynia – a simple bedside test indicative of fibromyalgia: a multicenter developmental study. Journal of Clinical Rheumatology. 2006;12:272–274

PII: S1521-6942(07)00040-X

doi: 10.1016/j.berh.2007.03.006

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 3 , Pages 481-497 , June 2007

Article Tools